Skip to main content
OpenTrials
Completed

NCT Number: NCT04048057

The Effect of Different Exercise Programs in Coronary Artery Patients: A Randomized Controlled Study

There are studies showing the superiority of HIIT protocols in patients with CAD in the literature, however there is no consensus on the use of HIIT protocols in CAD patients. In addition, in these studies, the HIIT protocols differ in severity and duration and there is no optimal HIIT protocol. Therefore, this study was planed to investigate of two different HIIT protocols and one MICT protocols, which are more commonly used in patients with CAD in the literature on exercise capacity, quality of life, body composition, physical activity level and fear of movement.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kutahya Health Sciences University

Kütahya, Center, 43100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have undergone percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery,
  • Nonobstructive CAD registered by angiography
  • Left ventricular ejection fraction above 50%,
  • Clinically stable for more than 2 weeks in terms of symptoms and medical treatment.

Exclusion criteria

  • Ischemia symptoms,
  • Being in Class III-IV according to the New York Heart Classification,
  • Obtaining significant left ventricular outflow obstruction,
  • Ventricular arrhythmia,
  • Being marked valvular heart disease,
  • Failure to comply with exercise testing and training rules,
  • To have significant orthopedic or neurological comorbidity that prevents full participation.

Treatment and study plan

Exercise

Other

Modarete Intensity Continous Training: Medium intensity continuous exercise training will be performed. Exercise intensity will be adjusted as 50-70% of maximal power.

High Intensity Interval Training I: It will be four cycles consisting of 4 minute high intensity exercise phase and 3 minute active recovery phase. High intensity phase will be adjusted as 85-100% of maximal power and active recovery phase as 50-70% of maximal power.

High Intensity Interval Training II: It will be 10 cycles consisting of 1 minute high intensity exercise phase and 1 minute active recovery phase. High intensity phase will be adjusted as 85-100% of maximal power and active recovery phase as 50-70% of maximal power.

Primary outcomes

  1. exercise capacity

    Time frame: 15 minutes

    Cardiopulmonary exercise test

Secondary outcomes

  1. MacNew Health Related Quallity of Life Qustionnaire

    Time frame: 15 minutes

    The validity and reliability of the MacNew Heart Disease Health-Related Quality of Life Questionnaire Daşkapan et al. in 2008. It is a scale developed to determine the quality of life in heart diseases consisting of 27 items each containing a 7-point Likert type response. In the evaluation of the scale, 3 sub-dimensions (emotional, physical and social) and total score values are used

  2. body composition

    Time frame: 1 minute

    Tanita

  3. physical activity level

    Time frame: 15 minutes

    International Physical Activity Questionnaire

  4. fear of movement

    Time frame: 15 minutes

    Tampa

Sponsors and collaborators

Lead sponsor

Kutahya Health Sciences University

Other

Registry information

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Aug 7, 2019
Registry last updated
Aug 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.